Light‐chain amyloid myopathy isolated to skeletal muscles: A case report
Abstract Isolated amyloidosis, especially of amyloid light‐chain type, is an infrequent disease. Systemic chemotherapy for light‐chain amyloidosis isolated to skeletal muscles plays a key role to reduce clonal plasma cells producing aberrant immunoglobulin.
Main Authors: | Toshihiro Matsukawa, Katsuki Eguchi, Ichizo Nishino, Kohei Okada, Kazuo Oshimi, Takuto Miyagishima |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3310 |
Similar Items
-
Amyloid myopathy: a diagnostic challenge
by: Heli Tuomaala, et al.
Published: (2009-08-01) -
Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report
by: Erina Ono, et al.
Published: (2021-02-01) -
Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review
by: Hongbin Yu, et al.
Published: (2022-07-01) -
Amyloid light-chain deposition in a schwannoma
by: Megan M. Jack, et al.
Published: (2021-12-01) -
Amyloid and amyloidosis /
by: Skinner, Martha, et al.
Published: (2005)